Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483171 · ClinicalTrials.gov registry record · Phase 3
A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients
A Phase 3 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 3
- Development phase
- 699
- Enrollment target
NCT00483171 is a Phase 3 study that was terminated before completion, run by Pfizer. The registered enrollment target is 699 participants.
The verdict
NCT00483171, a Phase 3 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 699 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if CP-945,598 is effective in the prevention of weight regain in obese subjects.
Interventions
- BEHAVIORAL Low Calorie Diet
- DRUG CP-945,598
- BEHAVIORAL Non-pharmacological weight loss program (NPP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 699 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00483171
The ClinicalTrials.gov registry entry for NCT00483171 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 699 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Low Calorie Diet is the first listed.
NCT00483171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00483171 about?
NCT00483171 is a clinical study titled "A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients". The purpose of this study is to determine if CP-945,598 is effective in the prevention of weight regain in obese subjects.
What is the current status of trial NCT00483171?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 699 participants. The study started on 2008-01. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00483171?
The interventions under investigation include: Low Calorie Diet (BEHAVIORAL), CP-945,598 (DRUG), Non-pharmacological weight loss program (NPP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00483171?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.